Sign In  |  Register  |  About Corte Madera  |  Contact Us

Corte Madera, CA
September 01, 2020 10:27am
7-Day Forecast | Traffic
  • Search Hotels in Corte Madera

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:

GloriaBio Approved to Launch PD-1 in China for Hodgkin's Lymphoma

Gloria Biosciences was approved to launch its anti-PD-1 mAb to treat recurrent or refractory classical Hodgkin’s lymphoma. The PD-1, zimberelimab, was discovered by CRO WuXi Biotech using Ligand Pharma's OmniRat® program. Gloria has rights to zimberelimab in China . GloriaBio is also testing zimberelimab in solid tumors and has been granted Breakthrough status for cervical cancer patients in China. The company, also known as Guangzhou Yuheng Biological, was established in 2016 by Yuheng Pharma and WuXi Biotech. More details.... Share this with colleagues: // //
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
Copyright © 2010-2020 CorteMadera.com & California Media Partners, LLC. All rights reserved.